{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:15:21Z","timestamp":1794431721856,"version":"4.9.1"},"reference-count":214,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.fertnstert.2024.09.038","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:34:46Z","timestamp":1727300086000},"page":"457-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-0055","authenticated-orcid":false,"given":"Alessandro","family":"Conforti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Gabriele","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Campitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Ubaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rienzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vaiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Cimadomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ronsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Longobardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u2019Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro C.","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.09.038_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/humrep\/dem408","article-title":"A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause","volume":"23","author":"Hansen","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/humupd\/dmt057","article-title":"Environmental and developmental origins of ovarian reserve","volume":"20","author":"Richardson","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib3","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jcem.87.5.8459","article-title":"Hypersecretion of FSH in infant boys and girls born small for gestational age","volume":"87","author":"Ib\u00e1\u00f1ez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0015-0282(16)56875-7","article-title":"Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test","volume":"62","author":"Sharara","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib5","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/humrep\/12.8.1736","article-title":"Effects of cigarette smoking and age on the maturation of human oocytes","volume":"12","author":"Zenzes","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0140-6736(92)92895-M","article-title":"Smoking and decreased fertilisation rates in\u00a0vitro","volume":"340","author":"Rosevear","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/humupd\/dmaa018","article-title":"Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary","volume":"26","author":"Ding","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib8","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00018-019-03028-1","article-title":"Establishment and depletion of the ovarian reserve: physiology and impact of environmental chemicals","volume":"76","author":"Ge","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fendo.2020.00453","article-title":"Bisphenol A-induced epigenetic changes and its effects on the male reproductive system","volume":"11","author":"Cariati","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization","volume":"94","author":"Broekmans","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/GCO.0b013e32833b4f5c","article-title":"Tests for ovarian reserve: reliability and utility","volume":"22","author":"Domingues","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2019.12.019","article-title":"Ovarian reserve tests: are they only a quantitative measure?","volume":"113","author":"Alviggi","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.rbmo.2017.06.027","article-title":"Significant correlation between anti-M\u00fcllerian hormone and embryo euploidy in a subpopulation of infertile patients","volume":"35","author":"Gat","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.fertnstert.2019.11.014","article-title":"Diminished ovarian reserve in recurrent pregnancy loss: a systematic review and meta-analysis","volume":"113","author":"Bunnewell","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib19","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.fertnstert.2016.06.016","article-title":"Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in\u00a0vitro fertilization","volume":"106","author":"Shahine","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s43032-022-01091-x","article-title":"Live birth rates in women under 38 years old with AMH level < 1.2 ng\/ml in the first in\u00a0vitro fertilization +\/\u2013 Intracytoplasmic Sperm Injection: retrospective study and arguments for care","volume":"30","author":"Morcel","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib21","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/humrep\/dey238","article-title":"Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance","volume":"33","author":"Morin","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12958-018-0442-y","article-title":"Does the \u201cdelayed start\u201d protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? A randomized clinical trial","volume":"16","author":"Ashrafi","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","article-title":"Does the addition of growth hormone to the in\u00a0vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial","volume":"105","author":"Bassiouny","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijgo.2015.05.034","article-title":"Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response","volume":"131","author":"Bayoumi","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dex208","article-title":"Efficacy and safety of follitropin alfa\/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders","volume":"32","author":"Humaidan","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/1471-0528.17045","article-title":"Effect of dehydroepiandrosterone administration before in\u00a0vitro fertilization on the live birth rate in poor ovarian responders according to the Bologna criteria: a randomised controlled trial","volume":"129","author":"Wang","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib27","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLOS MED"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fendo.2019.00387","article-title":"Management of women with an unexpected low ovarian response to gonadotropin","volume":"10","author":"Conforti","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib31","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3389\/fendo.2019.00814","article-title":"The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists","volume":"10","author":"Esteves","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib32","doi-asserted-by":"crossref","first-page":"587051","DOI":"10.3389\/fendo.2021.587051","article-title":"Improving reporting of clinical studies using the POSEIDON criteria: POSORT guidelines","volume":"12","author":"Esteves","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jrsm.1599","article-title":"Identifying and managing problematic trials: a research integrity assessment tool for randomized controlled trials in evidence synthesis","volume":"14","author":"Weibel","year":"2023","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/0962280219889080","article-title":"Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib35","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/sim.4029","article-title":"Confidence intervals for random effects meta-analysis and robustness to publication bias","volume":"29","author":"Henmi","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/09513590.2012.705386","article-title":"DHEA supplementation improves follicular microenviroment in poor responder patients","volume":"28","author":"Artini","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib37","first-page":"593","article-title":"Evaluation of ovulation induction protocols for poor responders undergoing assisted reproduction techniques","volume":"26","author":"Ashrafi","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00404-012-2522-0","article-title":"A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor-responding patients","volume":"287","author":"Davar","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/humrep\/10.1.40","article-title":"Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study","volume":"10","author":"Dor","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib40","doi-asserted-by":"crossref","first-page":"926172","DOI":"10.1155\/2014\/926172","article-title":"LH pretreatment as a novel strategy for poor responders","volume":"2014","author":"Ferraretti","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijgo.12988","article-title":"Randomized controlled trial of gonadotropin-releasing hormone agonist microdose flare-up versus flare-up among poor responders undergoing intracytoplasmic sperm injection","volume":"148","author":"Ghaffari","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib42","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/09513590.2019.1576621","article-title":"Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study","volume":"35","author":"Haas","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib43","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.fertnstert.2009.05.013","article-title":"Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib44","first-page":"2010","article-title":"The effects of letrozole + GnRH antagonist versus mere GNRH antagonist during IVF in patients with poor ovarian response","volume":"14","author":"Mehrabian","year":"2021","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib45","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.fertnstert.2003.11.031","article-title":"A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in\u00a0vitro fertilization","volume":"81","author":"Morgia","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2147\/IJWH.S117577","article-title":"Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients","volume":"8","author":"Selman","year":"2016","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib47","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.4081\/ejtm.2022.10634","article-title":"Comparison of two ovarian stimulation protocols among women with poor response: a randomized clinical trial","volume":"32","author":"Bavarsadkarimi","year":"2022","journal-title":"Eur J Transl Myol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2161-0932.1000158","article-title":"Clomiphene citrate plus modified GnRH antagonist protocol for women with poor ovarian response undergoing ICSI treatment cycles: randomized controlled trial","volume":"3","author":"Abdel-Mohsen","year":"2013","journal-title":"Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib49","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/humrep\/16.5.868","article-title":"Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial","volume":"16","author":"Akman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.fertnstert.2006.11.150","article-title":"Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders","volume":"88","author":"Berkkanoglu","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","article-title":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","volume":"94","author":"Berkkanoglu","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF02765836","article-title":"Gonadotropins and glucocorticoid therapy for \u201clow responders\u201d\u2014a controlled study","volume":"14","author":"Bider","year":"1997","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib53","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deh668","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial","volume":"20","author":"Cheung","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1028-4559(10)60064-2","article-title":"GnRH Antagonist\/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in\u00a0vitro fertilization","volume":"49","author":"Davar","year":"2010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humrep\/deh625","volume":"20","author":"De Placido","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib56","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.fertnstert.2011.01.134","article-title":"A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders","volume":"95","author":"DiLuigi","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib57","first-page":"101","article-title":"Letrozole + GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: an RCT","volume":"15","author":"Ebrahimi","year":"2017","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib58","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","article-title":"Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology","volume":"287","author":"Eftekhar","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib59","first-page":"725","article-title":"Comparison of pregnancy outcome after letrozole versus clomiphene treatment for mild ovarian stimulation protocol in poor responders","volume":"12","author":"Eftekhar","year":"2014","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/humrep\/den428","article-title":"Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial","volume":"24","author":"F\u00e1bregues","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib61","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3109\/09513590.2011.579661","article-title":"Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET","volume":"27","author":"Fouda","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib62","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.fertnstert.2006.04.046","article-title":"\u201cOvarian age-based\u201d stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in\u00a0vitro fertilization","volume":"86","author":"Gleicher","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib63","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/deh359","article-title":"A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report","volume":"19","author":"Goswami","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib64","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00404-010-1828-z","article-title":"Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders","volume":"283","author":"Karimzadeh","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.12717\/DR.2014.18.3.145","article-title":"Ovarian features after 2 weeks, 3 weeks and 4 weeks transdermal testosterone gel treatment and their associated effect on IVF outcomes in poor responders","volume":"18","author":"Kim","year":"2014","journal-title":"Dev Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib66","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.fertnstert.2009.06.005","article-title":"Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/humrep\/deu301","article-title":"Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial","volume":"30","author":"Kolibianakis","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib68","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/humrep\/det266","article-title":"Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF\/ICSI: a randomized controlled multicentre study","volume":"28","author":"K\u00f6nig","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib69","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1447-0756.2008.00750.x","article-title":"Efficiency of follicle-stimulating hormone, commenced in the luteal phase, for overcoming a poor response in assisted reproduction","volume":"34","author":"Kucuk","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib70","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/humrep\/deac113","article-title":"Increased versus standard gonadotrophin dosing in predicted poor responders of IVF: an open-label randomized controlled trial","volume":"37","author":"Liu","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib71","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10815-012-9854-3","article-title":"Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial","volume":"29","author":"Madani","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib72","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.fertnstert.2005.01.139","article-title":"Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation","volume":"84","author":"Malmusi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib73","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/humrep\/dei481","article-title":"Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique\u2014a prospective, randomized, double-blind study","volume":"21","author":"Massin","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12978-015-0039-2","article-title":"Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy","volume":"12","author":"Merviel","year":"2015","journal-title":"Reprod Health"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.mefs.2012.11.002","article-title":"Long-term androgen priming by use of dehydroepiandrosterone (DHEA) improves IVF outcome in poor-responder patients. A randomized controlled study","volume":"17","author":"Moawad","year":"2012","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/09513590.2012.730569","article-title":"Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI","volume":"29","author":"Mohsen","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib77","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/humrep\/der371","article-title":"The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve","volume":"27","author":"Musters","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib78","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5539\/gjhs.v8n4p166","article-title":"Comparison of GnRh agonist microdose flare up and GnRh antagonist\/letrozole in treatment of poor responder patients in intra cytoplaspic sperm injection: randomized clinical trial","volume":"8","author":"Nabati","year":"2015","journal-title":"Glob J Health Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib79","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.rbmo.2019.02.003","article-title":"Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate","volume":"38","author":"Norman","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib80","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.rbmo.2009.05.007","article-title":"Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols","volume":"19","author":"Ozmen","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib81","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.fertnstert.2011.08.020","article-title":"Does metformin affect the ovarian response to gonadotropins for in\u00a0vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial","volume":"96","author":"Palomba","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib82","first-page":"35","article-title":"Comparison pregnancy outcomes between minimal stimulation protocol and conventional GnRH antagonist protocols in poor ovarian responders","volume":"10","author":"Pilehvari","year":"2016","journal-title":"J Family Reprod Health"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib83","first-page":"4354","article-title":"Short gonadotropin-releasing hormone agonist versus flexible antagonist versus clomiphene citrate regimens in poor responders undergoing in\u00a0vitro fertilization: a randomized controlled trial","volume":"20","author":"Schimberni","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-015-0014-3","article-title":"Dehydroepiandrosterone decreases the age-related decline of the in\u00a0vitro fertilization outcome in women younger than 40 years old","volume":"13","author":"Tartagni","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib85","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib86","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/humrep\/dev038","article-title":"Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged \u226535 years: a randomized controlled trial","volume":"30","author":"Vuong","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib87","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3109\/09513590.2011.569611","article-title":"Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels","volume":"27","author":"Weissman","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib88","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/deq220","article-title":"Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study","volume":"25","author":"Wiser","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib89","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/cen.12886","article-title":"The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study","volume":"84","author":"Younis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib90","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/humrep\/deac114","article-title":"Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles","volume":"37","author":"Zhou","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib91","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.rbmo.2011.05.012","article-title":"Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial","volume":"23","author":"Lee","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40834-024-00265-z","article-title":"Comparison of luteal phase stimulation with follicular phase stimulation in poor ovarian response: a single-blinded randomized controlled trial","volume":"9","author":"Dastjerdi","year":"2024","journal-title":"Contracept Reprod Med"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib93","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/humrep\/dead276","article-title":"Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial","volume":"39","author":"Boudry","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib94","first-page":"467","article-title":"Comparison of the effects of two different trigger strategies\u2013\u2013dual (hCG + Leuprolide) versus hCG trigger\u2013\u2013in antagonist non-donor IVF: a randomized controlled trial","volume":"27","author":"Singh","year":"2023","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib95","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15296\/ijwhr.2022.34","article-title":"The comparison the impact of flare-up GnRH agonist with delayed-start GnRH antagonist protocols on the IVF outcome of poor responder patients: a randomized controlled trial","volume":"10","author":"Hosseinishenatal","year":"2022","journal-title":"Int J Womens Health Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib96","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10815-007-9178-x","article-title":"Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function","volume":"24","author":"Barad","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib97","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00404-020-05603-5","article-title":"Ovarian stimulation after dehydroepiandrosterone supplementation in poor ovarian reserve: a randomized clinical trial","volume":"302","author":"Elprince","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13224-016-0941-8","article-title":"Evaluation of dehydroepiandrosterone supplementation on diminished ovarian reserve: a randomized, double-blinded, placebo-controlled study","volume":"67","author":"Agarwal","year":"2017","journal-title":"J Obstet Gynaecol India"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib99","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-1208.165142","article-title":"Dehydroepiandrosterone as an adjunct to gonadotropins in infertile Indian women with premature ovarian aging: a pilot study","volume":"8","author":"Malik","year":"2015","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib101","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/09513590.2015.1092136","article-title":"Which is the best IVF\/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial","volume":"32","author":"Dakhly","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib102","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1210\/jc.2015-1194","article-title":"Antral follicle priming before intracytoplasmic sperm injection in previously diagnosed low responders: a randomized controlled trial (FOLLPRIM)","volume":"100","author":"Escriva","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12020-015-0744-1","article-title":"Rescue in\u00a0vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR)","volume":"52","author":"Lee","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib104","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.fertnstert.2015.08.014","article-title":"450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial","volume":"104","author":"Lefebvre","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.rbmo.2016.11.014","article-title":"Effect of mid-follicular phase recombinant LH versus urinary HCG supplementation in poor ovarian responders undergoing IVF - a prospective double-blinded randomized study","volume":"34","author":"Mak","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib106","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10815-020-01742-5","article-title":"A prospective randomized trial comparing corifollitropin-\u03b1 late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVF","volume":"37","author":"Revelli","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib107","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/jhrs.JHRS_125_18","article-title":"Does double dose of recombinant human chorionic gonadotropin for final follicular maturation in in\u00a0vitro fertilization cycles improve oocyte quality: a prospective randomized study","volume":"12","author":"Singh","year":"2019","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12958-016-0139-z","article-title":"Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial","volume":"14","author":"Zhang","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib109","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/deae104","article-title":"Double versus single stimulation in young low prognosis patients followed by a fresh embryo transfer: a randomized controlled trial (DUOSTIM-fresh)","volume":"39","author":"Racca","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5505\/tjod.2013.79027","article-title":"Comparison of microdose GnRH agonist protocol with GnRH antagonist\/letrazole protocol in patients with poor ovarian response","volume":"10","author":"\u00c7akiro\u01e7lu","year":"2013","journal-title":"Turk J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/09513590.2017.1332586","article-title":"The effectiveness of transdermal testosterone gel 1% (androgel) for poor responders undergoing in\u00a0vitro fertilization","volume":"33","author":"Doan","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib111","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1177\/1933719115590666","article-title":"Delayed start versus conventional GnRH antagonist protocol in poor responders pretreated with estradiol in luteal phase: a randomized controlled trial","volume":"22","author":"Maged","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib112","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijgo.13405","article-title":"Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: a randomized controlled study","volume":"152","author":"Maged","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib113","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.31557\/APJCP.2019.20.7.2033","article-title":"Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study","volume":"20","author":"Safdarian","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib114","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5001\/omj.2018.92","article-title":"Delayed start protocol with gonadotropin-releasing hormone antagonist in poor responders undergoing in\u00a0vitro fertilization: a randomized, double-blinded, clinical trial","volume":"33","author":"Zarei","year":"2018","journal-title":"Oman Med J"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tjog.2020.10.003","article-title":"Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF\/ICSI for poor responders; randomized controlled trial","volume":"60","author":"Mohammad","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib116","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12958-020-00648-2","article-title":"Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial","volume":"18","author":"Gong","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib117","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejogrb.2018.06.035","article-title":"The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in\u00a0vitro fertilization: randomized control trial","volume":"228","author":"Dakhly","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.36295\/ASRO.2019.220925","article-title":"Efficacy of transdermal testosterone in assisted reproduction outcome of poor responders","volume":"22","author":"Al-Jeborry","year":"2019","journal-title":"Ann Trop Med Public Health"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib119","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5005\/jp-journals-10006-2278","article-title":"The effect of transdermal testosterone gel pretreatment on IVF outcomes in patients with poor ovarian reserve","volume":"15","author":"Sharma","year":"2023","journal-title":"J South Asian Fed Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.25258\/ijddt.13.1.46","article-title":"The effect of testosterone gel for patients with poor ovarian response prior to IVF cycles: is it really effective?","volume":"13","author":"Muhammed","year":"2023","journal-title":"Int J Drug Deliv Technol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejogrb.2016.02.009","article-title":"Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF\/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial","volume":"200","author":"Kotb","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib122","first-page":"231","article-title":"Pregnancy outcome of \u201cdelayed start\u201d GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: a clinical trial study","volume":"15","author":"Aflatoonian","year":"2017","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib123","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mefs.2018.04.011","article-title":"A comparison of dual triggering (by administration of GnRH agonist plus HCG) versus HCG alone in poor ovarian responders in ART outcomes","volume":"23","author":"Eftekhar","year":"2018","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib124","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/humrep\/dex321","article-title":"Individualized FSH dosing based on ovarian reserve testing in women starting IVF\/ICSI: a multicentre trial and cost-effectiveness analysis","volume":"32","author":"van Tilborg","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2096-2924.210696","article-title":"Effects of dehydroepiandrosterone on embryo quality and follicular fluid markers in patients with diminished ovarian reserves","volume":"1","author":"Fu","year":"2017","journal-title":"Reprod Dev Med"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib127","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2013.11.008","article-title":"Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?","volume":"173","author":"Kara","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.09.006","article-title":"Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): a proof of principle double blinded randomized placebo controlled trial","volume":"218","author":"Narkwichean","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib129","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","article-title":"A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in\u00a0vitro fertilization outcomes in poor responders","volume":"102","author":"Yeung","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13048-014-0093-3","article-title":"Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in\u00a0vitro fertilization: a randomized controlled trial","volume":"7","author":"Zhang","year":"2014","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib131","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/humrep\/dew028","article-title":"Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial","volume":"31","author":"Bosdou","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib132","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmb2.12383","article-title":"Therapeutic effect of prolonged testosterone pretreatment in women with poor ovarian response: a randomized control trial","volume":"20","author":"Hoang","year":"2021","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib133","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","article-title":"The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib134","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/jrms.JRMS_864_17","article-title":"The effect of testosterone gel on fertility outcomes in women with a poor response in in\u00a0vitro fertilization cycles: a pilot randomized clinical trial","volume":"23","author":"Saharkhiz","year":"2018","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.rbmo.2021.05.021","article-title":"Testosterone does not improve ovarian response in Bologna poor responders: a randomized controlled trial (TESTOPRIM)","volume":"43","author":"Subir\u00e1","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib136","first-page":"112","article-title":"A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial","volume":"32","author":"Youssef","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib137","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib138","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10815-014-0227-y","article-title":"\u201cMild\u201d vs. \u201clong\u201d protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in\u00a0vitro fertilization (IVF): a large prospective randomized trial","volume":"31","author":"Revelli","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib139","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00404-020-05513-6","article-title":"Mild stimulation protocol vs conventional controlled ovarian stimulation protocol in poor ovarian response patients: a prospective randomized controlled trial","volume":"301","author":"Liu","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib140","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.fertnstert.2014.01.050","article-title":"A novel \u201cdelayed start\u201d protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders","volume":"101","author":"Cakmak","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib141","first-page":"255","article-title":"Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF\/ICSI: an RCT","volume":"16","author":"Davar","year":"2018","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib142","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43043-021-00079-y","article-title":"Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial","volume":"26","author":"Esfidani","year":"2021","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib143","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/tbj.13474","article-title":"Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues","volume":"25","author":"Conforti","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib144","first-page":"3134","article-title":"High progesterone levels during the luteal phase related to the use of an aromatase inhibitor in breast cancer patients","volume":"21","author":"Alviggi","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib145","first-page":"322","article-title":"Oncofertilit\u00e0: dove siamo?","volume":"41","author":"Vallone","year":"2017","journal-title":"Biochimica Clinica"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib146","doi-asserted-by":"crossref","first-page":"2125.e9","DOI":"10.1016\/j.fertnstert.2011.01.030","article-title":"Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles","volume":"95","author":"S\u00f6nmezer","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib147","first-page":"CD010287","article-title":"Aromatase inhibitors for subfertile women with polycystic ovary syndrome","author":"Franik","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib148","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/humupd\/dms003","article-title":"Aromatase inhibitors for PCOS: a systematic review and meta-analysis","volume":"18","author":"Misso","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib149","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib150","first-page":"653","article-title":"Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: a double-blind randomized clinical trial","volume":"17","author":"Moini","year":"2019","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib151","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1177\/0300060518770346","article-title":"Comparison of modified agonist, mild-stimulation and antagonist protocols for in\u00a0vitro fertilization in patients with diminished ovarian reserve","volume":"46","author":"Yu","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib152","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/2.6.483","article-title":"Development, pharmacology and clinical experience with clomiphene citrate","volume":"2","author":"Dickey","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib153","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1026280508821","article-title":"Treatment-associated serum FSH levels in very poor responders to ovarian stimulation","volume":"20","author":"Saadat","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib154","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF02214121","article-title":"Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in\u00a0vitro fertilization patients","volume":"12","author":"Benadiva","year":"1995","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib155","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/humrep\/deaa336","article-title":"Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders","volume":"36","author":"Moffat","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib156","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1477-7827-10-114","article-title":"Clomiphene citrate versus high doses of gonadotropins for in\u00a0vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial","volume":"10","author":"Ragni","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib157","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.theriogenology.2008.12.015","article-title":"Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis","volume":"71","author":"Silva","year":"2009","journal-title":"Theriogenology"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib158","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0015-0282(16)57477-9","article-title":"Low-dose growth hormone-releasing factor may enhance folliculogenesis in regularly menstruating women: a preliminary study","volume":"63","author":"Duffy","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib159","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fendo.2019.00450","article-title":"The Role of growth hormone on ovarian functioning and ovarian angiogenesis","volume":"10","author":"Devesa","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib160","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1210\/en.2002-220087","article-title":"Growth hormone is required for ovarian follicular growth","volume":"143","author":"Bachelot","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib161","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0967199402002125","article-title":"Immunohistochemical localisation of growth hormone (GH), GH receptor (GHR), insulin-like growth factor I (IGF-I) and type I IGF-I receptor, and gene expression of GH and GHR in rat pre-antral follicles","volume":"10","author":"Zhao","year":"2002","journal-title":"Zygote"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib162","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00404-017-4613-4","article-title":"Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study","volume":"297","author":"Choe","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib163","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fendo.2019.00892","article-title":"Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders","volume":"10","author":"Lee","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib164","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/03009734.2020.1734694","article-title":"DuoStim\u2014a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review","volume":"125","author":"Vaiarelli","year":"2020","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.23736\/S0026-4784.19.04390-9","article-title":"Double stimulation in the same ovarian cycle (DuoStim) is an intriguing strategy to improve oocyte yield and the number of competent embryos in a short timeframe","volume":"71","author":"Vaiarelli","year":"2019","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib166","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fertnstert.2019.09.012","article-title":"Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series","volume":"113","author":"Vaiarelli","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib167","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/dey217","article-title":"Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle","volume":"33","author":"Cimadomo","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib168","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12958-020-00570-7","article-title":"Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial","volume":"18","author":"Ll\u00e1cer","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib169","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13048-015-0198-3","article-title":"A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist\/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation","volume":"8","author":"Orvieto","year":"2015","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","article-title":"Triggering final follicular maturation\u2013hCG, GnRH-agonist or both, when and to whom?","volume":"8","author":"Orvieto","year":"2015","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib171","doi-asserted-by":"crossref","first-page":"102633","DOI":"10.1016\/j.jogoh.2023.102633","article-title":"Cycle outcomes of dual trigger (GnRH agonist + hCG) versus human chorionic gonadotropin trigger alone in POSEDION group 3\u20134 poor-responders and normo-responders: a prospective randomized study","volume":"52","author":"Keskin","year":"2023","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib172","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/14647273.2017.1287433","article-title":"Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients","volume":"20","author":"Tsampras","year":"2017","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib173","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/humrep\/dead038","article-title":"The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF","volume":"38","author":"Massin","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib174","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.rbmo.2022.11.012","article-title":"A randomized, non-inferiority trial on the DuoStim strategy in PGT-A cycles","volume":"46","author":"Cerrillo","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1472-6483(10)61186-8","article-title":"Outlook: who needs LH in ovarian stimulation?","volume":"12","author":"Alviggi","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib176","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review","volume":"109","author":"Alviggi","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib177","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1472-6483(10)60865-6","article-title":"Exploiting LH in ovarian stimulation","volume":"12","author":"Alviggi","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib178","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-019-0460-4","article-title":"The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis","volume":"17","author":"Conforti","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib179","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12958-021-00759-4","article-title":"Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Conforti","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib180","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1038\/s41598-020-69325-z","article-title":"LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women","volume":"10","author":"Marchiani","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib181","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rbmo.2017.07.012","article-title":"Serum and follicular fluid testosterone concentrations do not correlate, questioning the impact of androgen supplementation on the follicular endocrine milieu","volume":"35","author":"von Wolff","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib182","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/01443615.2021.1873921","article-title":"Does LH supplementation in poor responders affect granulosa cells apoptosis rate in ART? A prospective randomised controlled trial","volume":"42","author":"Tosun","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib183","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/deg516","article-title":"Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib184","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/humrep\/deac081","article-title":"Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial","volume":"37","author":"Zhang","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib185","series-title":"Encyclopedia of reproduction","first-page":"9","article-title":"Drugs used for controlled ovarian stimulation","author":"Alviggi","year":"2018"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib186","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in\u00a0vitro fertilization","volume":"89","author":"Devroey","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib187","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1210\/jc.2004-0668","article-title":"Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility","volume":"89","author":"Balen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib188","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib189","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/humrep\/det045","article-title":"Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study","volume":"28","author":"Polyzos","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib190","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/humrep\/dex296","article-title":"Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial","volume":"32","author":"Drakopoulos","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib191","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-020-00628-6","article-title":"Corifollitropin alfa for poor responders patients, a prospective randomized study","volume":"18","author":"Fusi","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib192","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.fertnstert.2007.01.008","article-title":"In\u00a0vitro effect of dehydroepiandrosterone sulfate on steroid receptors, aromatase, cyclooxygenase-2 expression, and steroid hormone production in preovulatory human granulosa cells","volume":"88","author":"ElBeltagy","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib193","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib194","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0950-3552(97)80036-3","article-title":"Role of androgens in follicle maturation and atresia","volume":"11","author":"Hillier","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib195","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/dmq003","article-title":"Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models","volume":"16","author":"Walters","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib196","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib197","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/jog.14791","article-title":"Low basal serum testosterone level is detrimental to the embryo implantation in the patients with severe endometriosis","volume":"47","author":"Huang","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib198","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.fertnstert.2017.12.024","article-title":"Dehydroepiandrosterone enhances decidualization in women of advanced reproductive age","volume":"109","author":"Gibson","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib199","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0015-0282(00)00711-1","article-title":"Do androgens have a direct effect on endometrial function? An in\u00a0vitro study","volume":"74","author":"Tuckerman","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib200","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0015-0282(98)00007-7","article-title":"Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function","volume":"69","author":"Okon","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib201","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.fertnstert.2022.02.022","article-title":"Mild\/moderate versus full stimulation","volume":"117","author":"Alviggi","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib202","doi-asserted-by":"crossref","first-page":"E1987","DOI":"10.1210\/jc.2012-1738","article-title":"Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in\u00a0vitro fertilization cycles","volume":"97","author":"Labarta","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10815-022-02684-w","article-title":"Metaphase-II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case-control study in women of advanced maternal age","volume":"40","author":"Vaiarelli","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib204","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib205","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in\u00a0vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpobgyn.2022.05.003","article-title":"POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research","volume":"85","author":"Esteves","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib207","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/humrep\/dez100","article-title":"The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles","volume":"34","author":"Law","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib208","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib209","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.rbmo.2011.12.012","article-title":"Accumulation of oocytes: a new strategy for managing low-responder patients","volume":"24","author":"Cobo","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib211","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/humrep\/dead108","article-title":"Low-quality evidence from a randomized controlled trial due to an inappropriate IVF setting to challenge dual stimulation strategy","volume":"38","author":"Ubaldi","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib212","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1749-6632.1991.tb37925.x","article-title":"Influence of growth factors EGF, IGF-1, and human growth hormone on human endometrial stromal cells in\u00a0vitro","volume":"626","author":"Strowitzki","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib213","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fendo.2019.00653","article-title":"Growth hormone and endometrial receptivity","volume":"10","author":"Altm\u00e4e","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.09.038_bib214","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fendo.2018.00461","article-title":"Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria\u2014the why","volume":"9","author":"Esteves","year":"2018","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224022568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224022568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:34:38Z","timestamp":1769747678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224022568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":214,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0015028224022568"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.09.038","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}